iCAD announces positive three-year data using the Xoft System to treat skin cancer

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, has announced that positive data using the Company's Xoft® Axxent®Electronic Brachytherapy System® to treat non-melanoma skin cancer (NMSC) were presented at the American Society of Radiation Oncology's (ASTRO) 55th Annual Meeting being held from September 22-25, 2013 in Atlanta...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news